Source:http://linkedlifedata.com/resource/pubmed/id/18175813
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2008-1-7
|
pubmed:abstractText |
The immediate assessment of response to therapy is most beneficial to ovarian cancer patients. This study shows the correlation of drug-induced caspase activation determined by western blot analysis and by Caspase-Glotrade mark assay. Our findings demonstrate that the use of the Caspase-Glotrade mark assay allows a simple, fast, and sensitive alternative for the evaluation of in vitro response to chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1064-3745
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
414
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
79-82
|
pubmed:meshHeading |
pubmed-meshheading:18175813-Antineoplastic Agents,
pubmed-meshheading:18175813-Caspases,
pubmed-meshheading:18175813-Cell Line, Tumor,
pubmed-meshheading:18175813-Female,
pubmed-meshheading:18175813-Humans,
pubmed-meshheading:18175813-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:18175813-Ovarian Neoplasms,
pubmed-meshheading:18175813-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Correlation of caspase activity and in vitro chemo-response in epithelial ovarian cancer cell lines.
|
pubmed:affiliation |
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
|
pubmed:publicationType |
Journal Article
|